European Society of Toxicology In Vitro > News > ESTIV Applied Training Course shortlisted for LUSH Prize
27 July 2022

ESTIV Applied Training Course shortlisted for LUSH Prize

ESTIV is proud to announce that its training programme in NAMs (New approach Methodologies), the ESTIV Applied Training course, has been shortlisted for the 2022 LUSH prize.

The training course is organised annually since 2015 and has been recognised by EUROTOX as an activity leading to the ERT certification (module B.19).

Read more about the course here: https://www.estiv.org/projects-activities/training-course/about-the-course/

The Lush Training prize Shortlist 2022

About the LUSH PRIZE

Lush Prize Winners 2020

The Lush Prize offers a global prize fund to support initiatives to end or replace animal testing. It is the largest prize fund in the non-animal testing sector, with a prize fund of £250,000.

The Lush Prize rewards initiatives across science and campaigning that work to end or replace animal testing, particularly in the area of toxicology research.

There are five award categories: Lobbying, Training, Public Awareness, Science, and Young Researchers.

For the 2022 Prize there are 65 shortlisted organisations and individuals from 26 countries – see the full shortlist.

Winners will be announced in November at The Lush Prize 2022 Conference and Awards Ceremony, which will be held online.

Related content

Celebrating Talents in Toxicology: ESTIV Awards at ASCCT 2024

We are thrilled to announce the recipients of the ESTIV Awards recognizing outstanding early-career scientists at last week’s ASCCT Congress

ASCCT-ESTIV Award Winners Series: Dr. Eliska Kuchovska & Tiago Marques Pedro

  • News

Registration is open for the next joint ASCCT-ESTIV webinar featuring two excellent early career scientists and award recipients

Welcoming Luiz Ladeira to the ESTIV Board!

  • News

We are excited to announce that Dr. Luiz Ladeira has joined the ESTIV Board! Luiz brings exceptional expertise in physiological maps and AOP research, and a strong commitment to advancing in vitro and in silico toxicology.

Silver Sponsor

Memorandum of Understanding